Prevention and treatment of perinatal HIV-1 infection in the developing world

Current Opinion in Infectious Diseases

Volumn 13, Issue 3, 2000, Pages 247-251

  Coovadia, H M ^a  

^a UNIVERSITY OF NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CHLORHEXIDINE; COTRIMOXAZOLE; NEVIRAPINE; ZIDOVUDINE;

BREAST FEEDING; CESAREAN SECTION; CHORIOAMNIONITIS; CLINICAL TRIAL; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAUTERINE INFECTION; KAPOSI SARCOMA; MEMBRANE RUPTURE; OPPORTUNISTIC INFECTION; PATIENT COUNSELING; PERINATAL INFECTION; PNEUMONIA; PREMATURITY; REVIEW; VERTICAL TRANSMISSION;

EID: 0034042279     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200006000-00008     Document Type: Review

References (37)

1. 1 UNAIDS. AIDS epidemic update : December 1999. UNAIDS/WHO. 20 Avenue Appia, 1211 Geneva 27, Switzerland, 1999.
2. 2 Baggaley R, van Praag E. Organising the integration of voluntary counselling and testing for HIV infection in antenatal care. A practical guide. Office of HIV/AIDS and STIs, WHO, Geneva, Switzerland, 1999.
3. 3 Mofenson L. Short-course zidovudine for prevention of perinatal infection. Lancet 1999; 353:766-767. Concise and lucid commentary on the major antiretroviral trials undertaken in developing countries to reduce MTCT of HIV-1.
4. 4 Nduati R. Clinical studies of breast vs. formula feeding. Plenary Session Abstr. 047. Second conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants, Montreal, Canada. 1999/09/1-6.
5. 1 in Durban, South Africa: a prospective cohort study. Lancet 1999; 354:471-476. First prospective study of the impact of type of breastfeeding on MTCT of HIV-1.
6. 6 Leroy V, Newell ML, Dabis F, Peckham C, Van De Perre P, Bulterys M, et al. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Lancet 1998; 352:597-600.
7. 7 Bertolli J, St. Louis ME, Simonds RF, Nieburg P, Kamenga M, Brown C, et al. Estimating the timing of mother-to-child-transmission of human immunodeficiency virus in a breastfeeding population in Kinshasa, Zaire. J Infect Dis 1996; 174:722-726.
8. 8 Simonon A, Lepage P, Karita E, Hitimana DG, Dabis F, Msellati P, et al. An assessment of the timing of mother-to-child-transmission of human immunodeficiency virus type 1 by means of polymerase chain reaction. J Acquir Immune Defic Syndr 1994; 7:952-957.
9. 9 Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of Human Immunodeficiency Virus type 1 with zidovudine treatment. N Engl J Med 1994; 331:1173-1180.
10. 10 Shapiro DE, Sperling RS, Coombs REW. Effect of zidovudine on perinatal HIV-1 transmission and maternal viral load. Lancet 1999; 352:156. Compares the effects of mother's viral load on intrauterine transmission from the PACTG 076 and the 'Thai' studies.
11. 11 Dabis F, Msellati P, Meda N, Welffens-Ekra C, You B, Manigart O, et a/. Six-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. Lancet 1999; 353:786-792. A key study of short-course antiretrovirals used to reduce MTCT in breastfeeding women.
12. 12 Shatter N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet 1999; 353:773-780. A key study of short-course antiretrovirals used to reduce mother-to-child-transmission in non-breastfeeding women.
13. 13 Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, Severin ST, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial. Lancet 1999; 353:781-785. A key study of short-course antiretrovirals used to reduce MTCT in breastfeeding women.
14. 14 Shaffer N, Roongpisuthipong A, Siriwasin W, Chotpitayasunondh T, Chearskul S, Young NL, et al. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission. Thailand. J Infect Dis 1999; 179:590-599.
15. 15 Semba RD, Miotti PG, Chiphangwi JD, Saah AJ, Canner JK, Dallabetta GA, Hoover DR. Maternal vitamin A deficiency and mother-to-child-transmission of HIV-1. Lancet 1994; 343:1593-1597.
16. 1.
17. 17 Semba RD, Miotti PG, Tana TE. Maternal vitamin A supplementation and mother-to-child-transmission of HIV. International Vitamin A Consultative Group Meeting, Cairo, September 1997.
18. 18 Fawzi WW. Micronutrients and HIV transmission. Plenary Abstract No. 051. Second Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants. Montreal, Canada, 1999/09/1-6.
19. 19 Bobat R, Moodley D, Coutsoudis A, Coovadia HM. Breastfeeding by HIV-1 infected women and outcome in their infants: a cohort study from Durban, South Africa. AIDS 1997; 11:1627-1633.
20. 20 Goldenberg RL, Vermund SH, Goepfert AR, Andrews WW. Choriodecidual inflammation: a potentially preventable cause of perinatal HIV-1 transmission? Lancet 1998; 352:1927-1930.
21. 21 Biggars RJ, Miotti PG, Taha TE, Mtimavalye L, Broadhead R, Justesen A, et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet 1996; 347:1647-1650.
22. 22 The International Perinatal HIV Group. The Mode of Delivery and the risk of vertical transmission of human immunodeficiency virus type I. N Engl J Med 1999; 340:977-987. Meta-analysis of studies on caesarean section and mother to child transmission of HIV-1.
23. 23 The European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 1999; 353:1035-1039. Controlled trial on the same subject us in [22].
24. 24 Semprini AE, Castagna C, Ravizza M, Fiore S, Savasi V, Muggiasca ML, et al. The incidence of complications after caesarean section in 156 HIV-positive women. AIDS 1995; 9:913-917.
25. 25 Bulterys M, Chao A, Dushimimana A, Saah Z. Fatal complications after caesarian section in HIV-infected women. AIDS 1996; 10:923-924.
26. 26 Saba J. The results of the PETRA intervention trial to prevent perinatal transmission in sub-Saharan Africa. Sixth Conference in Retroviruses and Opportunistic Infections. Abstract S7. Chicago, IL. January 31-February 4, 1999.
27. 27 Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999; 354:795-802. Details of the widely publicized study showing the effectiveness of an extremely inexpensive and simple regimen to reduce MTCT of HIV-1.
28. 1 in Adbidjan, Cote d'Ivoire: long term follow-up in a breastfeeding population. Poster 234. Second Conference on Global Strategies for the Prevention of HIV Transmission from Mother to Infants, Montreal, Canada, Sept. 1-8, 1999.
29. 1 in the early postnatal period.
30. 30 Wade NA, Birkhead GS, Warren BL, Charbonneau TT, French PT, Wang L, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. New Engl J Med 1998; 339:1409-1414.
31. 1 through breastfeeding after the first few weeks of life.
32. 32 Tess BH, Rodrigues LC, Newell ML, Dunn DT, Lago TD. Infant feeding and risk of mother-to-child transmission of HIV-1 in São Paulo State, Brazil. São Paulo Collaborative Study for vertical transmission of HIV-1. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:189-194.
33. 33 Semba RD, Kumwenda N, Hoovar DR, Taha TE, Quinn TC. Mtimavalye L, et al. Human immunodeficiency virus load in breastmilk, mastitis and mother-to-child-transmission of human immunodeficiency virus type-1. J Infect Dis 1999; 180:93-98. A description of breast infection as a likely risk factor for breastmilk transmission of HIV-1.
34. 34 Willumsen FJ, Filtau SM, Coutaoudia A. Subclinical mastitis as a risk factor for mother-infant HIV transmission. In: Short and long term effects of breasrtfeeding on child health. Koltzko B, editor. International Society for Research on Human milk and Lactation. London: Plenum Publishing; 2000 (in press).
35. 35 Lepage P, Spira R, Kalibala S, Pillay K, Giaquinto C, Castetbon K, et al. Care of human immunodeficiency virus-infected children in developing countries. Pediatr Infect Dis J 1998; 17:581-586.
36. 36 Jeena PM, Coovadia HM, Thula SA, Blythe D, Buckels NJ, Chetty R. Persistent and chronic lung disease in HIV-1 infected and uninfected African children. AIDS 1998; 12:1165-83.
37. 37 Thejpal R, Vaithilingum M, Coovadia HM, Chetty R. Paediatric HIV infection. Lancet 1999; 348:1526-1527.